Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/16/2024
Strides Pharma obtains FDA OK for generic Prozac
Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia. - 4/16/2024
Meijer donates $250K to Council of the Great Lakes Region Foundation
The donation will help improve water and wildlife quality in river corridors throughout Wisconsin. - 4/16/2024
ANI debuts generic Fleqsuvy
Generic Fleqsuvy is a treatment for spasticity from multiple sclerosis, spinal cord injuries and other spinal cord diseases. - 4/16/2024
CVS Health works to increase value-based health care access in South Carolina
inVio Health Network and CVS Health’s Accountable Care Organization are partnering on a program aimed at improving the quality and health of 60,000 Medicare beneficiaries. - 4/16/2024
The Ginger People debuts new lozenges
The Ginger Rescue Lozenges are available in hard and soft formats. - 4/16/2024
NACDS highlights CDC study that underscores crucial role of pharmacy
A new CDC study underscores scalability of pharmacy-based services for future public health emergencies. - 4/15/2024
Avenacy debuts generic DDAVP
Desmopressin acetate for injection is multi-indicated for patients with central diabetes insipidus, hemophilia A and von Willebrand’s disease. - 4/15/2024
Intuity Medical partners with HealthHavenRx online pharmacy platform
By enabling an online pharmacy solution, people with diabetes can now obtain POGO Automatic online in addition to physical pharmacy stores. - 4/15/2024
NCPA launches CORE leadership program
Skills in financials, operations, marketing and leadership are the focus of the program. - 4/15/2024
Samsung Bioepis releases Q2 2024 U.S. biosimilar market report
As of April 2024, the FDA has approved a total of 48 biosimilars across 15 unique biological molecules, and of the 48 approvals, 38 biosimilars have launched in the U.S. market, per the report.
